NEUP
#4162
Neuphoria Therapeutics Inc. - Common Stock
5.3 1 USD
+0.57%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.57%
Monthly Change
+2.12%
6 month change
+20.68%
Year Change
-18.81%
Previous Close
5.2 8
Open
5.3 1
Low
5.3 1
High
5.3 1
Volume
1
Financials
- Market Capitalization 28.7 M
- Employee 8
- Founded 1996
- CEO N/A
- Website www.neuphoriatx.com
- Headquarter Australia
- FIGI BBG01RFZ8658
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-30.87
Price to sales ratio
0.74